{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:28:24Z","timestamp":1788485304286,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Innsbruck and Medical University of Innsbruck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Due to its versatility in formulation and manufacturing, self-emulsifying drug delivery systems (SEDDS) can be used to design parenteral formulations. Therefore, it is necessary to understand the effects of excipients on the behavior of SEDDS formulations upon parenteral administration, particularly their interactions with blood plasma and cell membranes. In this study, we prepared three neutrally charged SEDDS formulations composed of medium-chain triglycerides as the oil phase, polyoxyl-35 castor oil (EL35) and polyethylene glycol (15)-hydroxystearate (HS15) as the nonionic surfactants, medium-chain mono- and diglycerides as the co-surfactant, and propylene glycol as the co-solvent. The cationic surfactant, didodecyldimethylammonium bromide (DDA), and the anionic surfactant, sodium deoxycholate (DEO), were added to the neutral SEDDS preconcentrates to obtain cationic and anionic SEDDS, respectively. SEDDS were incubated with human blood plasma and recovered by size exclusion chromatography. Data showed that SEDDS emulsion droplets can bind plasma protein to different extents depending on their surface charge and surfactant used. At pH 7.4, the least protein binding was observed with anionic SEDDS. Positive charges increased protein binding. SEDDS stabilized by HS15 can adsorb more plasma protein and induce more plasma membrane disruption activity than SEDDS stabilized by EL35. These effects were more pronounced with the HS15\u2009+\u2009DDA combination. The addition of DDA and DEO to SEDDS increased plasma membrane disruption (PMD) activities, and DDA (1% w\/w) was more active than DEO (2% w\/w). PMD activities of SEDDS were concentration-dependent and vanished at appropriate dilution ratios.<\/jats:p>\n                <jats:p><jats:bold>Graphical abstract<\/jats:bold><\/jats:p>","DOI":"10.1007\/s13346-024-01541-w","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T15:45:27Z","timestamp":1709048727000},"page":"3200-3211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of excipients on the interactions of self-emulsifying drug delivery systems with human blood plasma and plasma membranes"],"prefix":"10.1007","volume":"14","author":[{"given":"Bao","family":"Le-Vinh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyet-Minh Nguyen","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Nhu Quynh","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hung Thanh","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4187-8277","authenticated-orcid":false,"given":"Andreas","family":"Bernkop-Schn\u00fcrch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,27]]},"reference":[{"key":"1541_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/J.BIOPHA.2004.02.001","volume":"58","author":"R Neslihan Gursoy","year":"2004","unstructured":"Neslihan Gursoy R, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173\u201382. https:\/\/doi.org\/10.1016\/J.BIOPHA.2004.02.001.","journal-title":"Biomed Pharmacother"},{"key":"1541_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ijpharm.2018.01.018","volume":"538","author":"J Griesser","year":"2018","unstructured":"Griesser J, Het\u00e9nyi G, Kadas H, Demarne F, Jannin V, Bernkop-Schn\u00fcrch A. Self-emulsifying peptide drug delivery systems: how to make them highly mucus permeating. Int J Pharm. 2018;538:159\u201366. https:\/\/doi.org\/10.1016\/j.ijpharm.2018.01.018.","journal-title":"Int J Pharm"},{"key":"1541_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/J.ADDR.2018.07.001","volume":"142","author":"A Mahmood","year":"2019","unstructured":"Mahmood A, Bernkop-Schn\u00fcrch A. A game changing approach for the oral administration of hydrophilic macromolecular drugs. Adv Drug Deliv Rev. 2019;142:91\u2013101. https:\/\/doi.org\/10.1016\/J.ADDR.2018.07.001.","journal-title":"Adv Drug Deliv Rev"},{"key":"1541_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijpharm.2007.09.015","volume":"351","author":"ME Perlman","year":"2008","unstructured":"Perlman ME, Murdande SB, Gumkowski MJ, Shah TS, Rodricks CM, Thornton-Manning J, Freel D, Erhart LC. Development of a self-emulsifying formulation that reduces the food effect for torcetrapib. Int J Pharm. 2008;351:15\u201322. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.09.015.","journal-title":"Int J Pharm"},{"key":"1541_CR5","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1080\/10717544.2022.2083724","volume":"29","author":"A Salawi","year":"2022","unstructured":"Salawi A. Self-emulsifying drug delivery systems: a novel approach to deliver drugs. Drug Deliv. 2022;29:1811\u201323. https:\/\/doi.org\/10.1080\/10717544.2022.2083724.","journal-title":"Drug Deliv"},{"key":"1541_CR6","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1002\/jps.24337","volume":"104","author":"RR Shah","year":"2015","unstructured":"Shah RR, Dodd S, Schaefer M, Ugozzoli M, Singh M, Otten GR, Amiji MM, O\u2019Hagan DT, Brito LA. The development of self-emulsifying oil-in-water emulsion adjuvant and an evaluation of the impact of Droplet size on performance. J Pharm Sci. 2015;104:1352\u201361. https:\/\/doi.org\/10.1002\/jps.24337.","journal-title":"J Pharm Sci"},{"issue":"12","key":"1541_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3390\/pharmaceutics11120667","volume":"11","author":"R Bastola","year":"2019","unstructured":"Bastola R, Seo JE, Keum T, Noh G, Choi JW, Il Shin J, Kim JH, Lee S. Preparation of squalene oil-based emulsion adjuvants employing a self-emulsifying drug delivery system and assessment of mycoplasma hyopneumoniae-specific Antibody titers in BALB\/c mice. Pharmaceutics. 2019;11(12):667. https:\/\/doi.org\/10.3390\/pharmaceutics11120667.","journal-title":"Pharmaceutics."},{"key":"1541_CR8","doi-asserted-by":"publisher","first-page":"6221","DOI":"10.2147\/IJN.S379950","volume":"17","author":"GE Chae","year":"2022","unstructured":"Chae GE, Kim DW, Jin HE. Development of squalene-based oil-in-Water Emulsion adjuvants using a self-emulsifying drug delivery system for enhanced Antigen-specific antibody titers. Int J Nanomed. 2022;17:6221. https:\/\/doi.org\/10.2147\/IJN.S379950.","journal-title":"Int J Nanomed"},{"key":"1541_CR9","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1208\/s12249-012-9809-0","volume":"13","author":"S He","year":"2012","unstructured":"He S, Cui Z, Mei D, Zhang H, Wang X, Dai W, Zhang Q. A cremophor-free self-microemulsified delivery system for intravenous injection of teniposide: evaluation in vitro and in vivo. AAPS PharmSciTech. 2012;13:846\u201352. https:\/\/doi.org\/10.1208\/s12249-012-9809-0.","journal-title":"AAPS PharmSciTech"},{"key":"1541_CR10","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1111\/J.1537-2995.2006.01000.X","volume":"46","author":"V Jouan-Hureaux","year":"2006","unstructured":"Jouan-Hureaux V, Audonnet-Blaise S, Lacatusu D, Krafft MP, Dewachter P, Cauchois G, Stoltz JF, Longrois D, Menu P. Effects of a new perfluorocarbon emulsion on human plasma and whole-blood viscosity in the presence of albumin, hydroxyethyl starch, or modified fluid gelatin: an in vitro rheologic approach. Transfusion. 2006;46:1892\u20138. https:\/\/doi.org\/10.1111\/J.1537-2995.2006.01000.X.","journal-title":"Transfusion"},{"key":"1541_CR11","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1134\/S0006350912020261\/METRICS","volume":"57","author":"VK Zhalimov","year":"2012","unstructured":"Zhalimov VK, Sklifas AN, Kukushkin NI. Mechanisms of human plasma protein adsorption on the surface of perfluorocarbon emulsion stabilized with proxanol 268. Biophys (Russian Fed. 2012;57:215\u201321. https:\/\/doi.org\/10.1134\/S0006350912020261\/METRICS.","journal-title":"Biophys (Russian Fed"},{"key":"1541_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0939-6411(02)00081-4","volume":"54","author":"A Gessner","year":"2002","unstructured":"Gessner A, Lieske A, Paulke B, M\u00fcller R. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur J Pharm Biopharm. 2002;54:165\u201370. https:\/\/doi.org\/10.1016\/S0939-6411(02)00081-4.","journal-title":"Eur J Pharm Biopharm"},{"key":"1541_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/J.ADDR.2009.03.009","volume":"61","author":"P Aggarwal","year":"2009","unstructured":"Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev. 2009;61:428. https:\/\/doi.org\/10.1016\/J.ADDR.2009.03.009.","journal-title":"Adv Drug Deliv Rev"},{"key":"1541_CR14","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.2147\/IJN.S49770","volume":"8","author":"H Kettiger","year":"2013","unstructured":"Kettiger H, Schipanski A, Wick P, Huwyler J. Engineered nanomaterial uptake and tissue distribution: from cell to organism. Int J Nanomed. 2013;8:3255\u201369. https:\/\/doi.org\/10.2147\/IJN.S49770.","journal-title":"Int J Nanomed"},{"key":"1541_CR15","doi-asserted-by":"publisher","DOI":"10.1021\/ACS.BIOCONJCHEM.3C00329","author":"M Debnath","year":"2023","unstructured":"Debnath M, James Forster I, Ramesh A, Kulkarni A. Protein Corona formation on lipid nanoparticles negatively affects the NLRP3 inflammasome activation. Bioconjug Chem. 2023. https:\/\/doi.org\/10.1021\/ACS.BIOCONJCHEM.3C00329.","journal-title":"Bioconjug Chem"},{"key":"1541_CR16","doi-asserted-by":"publisher","first-page":"18759","DOI":"10.1016\/S0021-9258(19)37026-7","volume":"267","author":"A Chonn","year":"1992","unstructured":"Chonn A, Semple SC, Cullis PR. Association of Blood Proteins with large unilamellar liposomes in vivo. J Biol Chem. 1992;267:18759\u201365.","journal-title":"J Biol Chem"},{"key":"1541_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2019.01.002","volume":"143","author":"Z Zhao","year":"2019","unstructured":"Zhao Z, Ukidve A, Krishnan V, Mitragotri S. Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers. Adv Drug Deliv Rev. 2019;143:3\u201321. https:\/\/doi.org\/10.1016\/j.addr.2019.01.002.","journal-title":"Adv Drug Deliv Rev"},{"key":"1541_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.CIS.2015.10.011","volume":"228","author":"M Manaargadoo-Catin","year":"2016","unstructured":"Manaargadoo-Catin M, Ali-Cherif A, Pougnas JL, Perrin C. Hemolysis by surfactants \u2014 a review. Adv Colloid Interface Sci. 2016;228:1\u201316. https:\/\/doi.org\/10.1016\/J.CIS.2015.10.011.","journal-title":"Adv Colloid Interface Sci"},{"key":"1541_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/J.AB.2007.07.027","volume":"372","author":"C Hoffmann","year":"2008","unstructured":"Hoffmann C, Leroy-Dudal J, Patel S, Gallet O, Pauthe E. Fluorescein isothiocyanate-labeled human plasma fibronectin in extracellular matrix remodeling. Anal Biochem. 2008;372:62\u201371. https:\/\/doi.org\/10.1016\/J.AB.2007.07.027.","journal-title":"Anal Biochem"},{"key":"1541_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3791\/50166","volume":"73","author":"BC Evans","year":"2013","unstructured":"Evans BC, Nelson CE, Yu SS, Beavers KR, Kim AJ, Li H, Nelson HM, Giorgio TD, Duvall CL. Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugs. J Vis Exp. 2013;73:7\u201311. https:\/\/doi.org\/10.3791\/50166.","journal-title":"J Vis Exp."},{"key":"1541_CR21","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/jphp.13021","volume":"71","author":"HT Lam","year":"2019","unstructured":"Lam HT, Le-Vinh B, Phan TNQ, Bernkop\u2010Schn\u00fcrch A. Self\u2010emulsifying drug delivery systems and cationic surfactants: do they potentiate each other in cytotoxicity? J Pharm Pharmacol. 2019;71:156\u201366. https:\/\/doi.org\/10.1111\/jphp.13021.","journal-title":"J Pharm Pharmacol"},{"key":"1541_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0169-409X(96)00490-5","volume":"25","author":"CW Pouton","year":"1997","unstructured":"Pouton CW. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev. 1997;25:47\u201358. https:\/\/doi.org\/10.1016\/S0169-409X(96)00490-5.","journal-title":"Adv Drug Deliv Rev"},{"key":"1541_CR23","series-title":"World Review Of Nutrition And Dietetics","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000365430","volume-title":"Intravenous Lipid Emulsions","author":"DF Driscoll","year":"2014","unstructured":"Driscoll DF.\u00a0Commercial Lipid Emulsions and All-in-One Mixtures for Intravenous Infusion-Composition and\u00a0Physicochemical Properties. In: Calder PC, Waitzberg DL, Koletzko B, editors. Intravenous Lipid Emulsions, vol. 4. World Review of Nutrition and Dietetics. S. Karger AG; 2014. p. 48\u201356. https:\/\/doi.org\/10.1159\/000365430."},{"key":"1541_CR24","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1021\/bi00457a006","volume":"29","author":"RJ Deckelbaum","year":"1990","unstructured":"Deckelbaum RJ, Hamilton JA, Moser A, Bengtsson-Olivecrona G, Butbul E, Carpentier YA, Gutman A, Olivecrona T. Medium-chain versus long-chain triacylglycerol emulsion hydrolysis by lipoprotein lipase and hepatic lipase: implications for the mechanisms of lipase action. Biochemistry. 1990;29:1136\u201342.","journal-title":"Biochemistry"},{"key":"1541_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/03639045.2017.1386202","volume":"44","author":"A Shah","year":"2018","unstructured":"Shah A, Thool P, Sorathiya K, Prajapati H, Dalrymple D, Serajuddin ATM. Effect of different polysorbates on development of self-microemulsifying drug delivery systems using medium chain lipids. Drug Dev Ind Pharm. 2018;44:215\u201323. https:\/\/doi.org\/10.1080\/03639045.2017.1386202.","journal-title":"Drug Dev Ind Pharm"},{"key":"1541_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/J.COLSURFA.2015.01.019","volume":"469","author":"E L\u00e9mery","year":"2015","unstructured":"L\u00e9mery E, Brian\u00e7on S, Chevalier Y, Bordes C, Oddos T, Gohier A, Bolzinger MA. Skin toxicity of surfactants: Structure\/toxicity relationships. Colloids Surf Physicochem Eng Asp. 2015;469:166\u201379. https:\/\/doi.org\/10.1016\/J.COLSURFA.2015.01.019.","journal-title":"Colloids Surf Physicochem Eng Asp"},{"key":"1541_CR27","doi-asserted-by":"publisher","first-page":"7098","DOI":"10.1016\/J.VACCINE.2014.10.036","volume":"32","author":"JT van Dissel","year":"2014","unstructured":"van Dissel JT, Joosten SA, Hoff ST, Soonawala D, Prins C, Hokey DA, O\u2019Dee DM, Graves A, Thierry-Carstensen B, Andreasen LV, Ruhwald M, de Visser AW, Agger EM, Ottenhoff THM, Kromann I, Andersen P. A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human. Vaccine. 2014;32:7098\u2013107. https:\/\/doi.org\/10.1016\/J.VACCINE.2014.10.036.","journal-title":"Vaccine"},{"key":"1541_CR28","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6:1078\u201394. https:\/\/doi.org\/10.1038\/s41578-021-00358-0.","journal-title":"Nat Rev Mater"},{"key":"1541_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/10717540590889691","volume":"12","author":"J Guo","year":"2005","unstructured":"Guo J, Wu T, Ping Q, Chen Y, Shen J, Jiang G. Solubilization and pharmacokinetic behaviors of sodium cholate\/lecithin-mixed micelles containing cyclosporine A. Drug Deliv. 2005;12:35\u20139. https:\/\/doi.org\/10.1080\/10717540590889691.","journal-title":"Drug Deliv"},{"key":"1541_CR30","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1021\/acs.molpharmaceut.0c00343","volume":"17","author":"AM J\u00f6rgensen","year":"2020","unstructured":"J\u00f6rgensen AM, Friedl JD, Wibel R, Chamieh J, Cottet H, Bernkop-Schn\u00fcrch A. Cosolvents in Self-Emulsifying Drug Delivery systems (SEDDS): do they really solve our solubility problems? Mol Pharm. 2020;17:3236\u201345. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.0c00343.","journal-title":"Mol Pharm"},{"key":"1541_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/J.COLSURFA.2008.07.061","volume":"331","author":"V Tchakalova","year":"2008","unstructured":"Tchakalova V, Testard F, Wong K, Parker A, Bencz\u00e9di D, Zemb T. Solubilization and interfacial curvature in microemulsions: I. Interfacial expansion and co-extraction of oil. Colloids Surf Physicochem Eng Asp. 2008;331:31\u20139. https:\/\/doi.org\/10.1016\/J.COLSURFA.2008.07.061.","journal-title":"Colloids Surf Physicochem Eng Asp"},{"key":"1541_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1021\/la8028879","volume":"25","author":"W Kunz","year":"2009","unstructured":"Kunz W, Testard F, Zemb T. Correspondence between curvature, packing parameter, and hydrophilic-lipophilic deviation scales around the phase-inversion temperature. Langmuir. 2009;25:112\u20135. https:\/\/doi.org\/10.1021\/la8028879.","journal-title":"Langmuir"},{"issue":"23","key":"1541_CR33","doi-asserted-by":"publisher","first-page":"13978","DOI":"10.1021\/ACS.ANALCHEM.8B03483","volume":"90","author":"M Schmid","year":"2018","unstructured":"Schmid M, H\u00e4usele B, Junk M, Brookes E, Frank J, C\u00f6lfen H. High-resolution asymmetrical flow field-flow fractionation data evaluation via richardson \u2013 lucy-based fractogram correction. Anal Chem. 2018;90:13978\u201386. https:\/\/doi.org\/10.1021\/ACS.ANALCHEM.8B03483.","journal-title":"Anal Chem."},{"key":"1541_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1021\/ja01157a122","volume":"72","author":"EJ Cohn","year":"1950","unstructured":"Cohn EJ, Gurd FRN, Surgenor DM, Barnes BA, Brown RK, Derouaux G, Gillespie JM, Kahnt FW, Lever WF, Liu CH, Mittelman D, Mouton RF, Schmid K, Uroma E. A system for the separation of the components of human blood: quantitative procedures for the separation of the protein components of human plasma. J Am Chem Soc. 1950;72:465\u201374. https:\/\/doi.org\/10.1021\/ja01157a122.","journal-title":"J Am Chem Soc"},{"key":"1541_CR35","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/JTH.12785","volume":"13","author":"AD Protopopova","year":"2015","unstructured":"Protopopova AD, Barinov NA, Zavyalova EG, Kopylov AM, Sergienko VI, Klinov DV. Visualization of fibrinogen \u03b1C regions and their arrangement during fibrin network formation by high-resolution AFM. J Thromb Haemost. 2015;13:570\u20139. https:\/\/doi.org\/10.1111\/JTH.12785.","journal-title":"J Thromb Haemost"},{"key":"1541_CR36","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1021\/JP409936V","volume":"118","author":"K Baler","year":"2014","unstructured":"Baler K, Martin OA, Carignano MA, Ameer GA, Vila JA, Szleifer I. Electrostatic unfolding and interactions of Albumin Driven by pH changes: a Molecular Dynamics Study. J Phys Chem B. 2014;118:921. https:\/\/doi.org\/10.1021\/JP409936V.","journal-title":"J Phys Chem B"},{"key":"1541_CR37","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0005-2736(91)90160-A","volume":"1070","author":"JH Senior","year":"1991","unstructured":"Senior JH, Trimble KR, Maskiewicz R. Interaction of positively-charged liposomes with blood: implications for their application in vivo. BBA - Biomembr. 1991;1070:173\u20139. https:\/\/doi.org\/10.1016\/0005-2736(91)90160-A.","journal-title":"BBA - Biomembr"},{"key":"1541_CR38","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/J.APSB.2020.10.023","volume":"11","author":"W Wang","year":"2021","unstructured":"Wang W, Huang Z, Li Y, Wang W, Shi J, Fu F, Huang Y, Pan X, Wu C. Impact of particle size and pH on protein corona formation of solid lipid nanoparticles: a proof-of-concept study. Acta Pharm Sin B. 2021;11:1030. https:\/\/doi.org\/10.1016\/J.APSB.2020.10.023.","journal-title":"Acta Pharm Sin B"},{"key":"1541_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/JBM.A.10371","volume":"65A","author":"A Gessner","year":"2003","unstructured":"Gessner A, Lieske A, Paulke BR, M\u00fcller RH. Functional groups on polystyrene model nanoparticles: influence on protein adsorption. J Biomed Mater Res Part A. 2003;65A:319\u201326. https:\/\/doi.org\/10.1002\/JBM.A.10371.","journal-title":"J Biomed Mater Res Part A"},{"key":"1541_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","volume":"307","author":"DE Owens","year":"2006","unstructured":"Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307:93\u2013102. https:\/\/doi.org\/10.1016\/j.ijpharm.2005.10.010.","journal-title":"Int J Pharm"},{"key":"1541_CR41","doi-asserted-by":"publisher","first-page":"2207218","DOI":"10.1002\/ADVS.202207218","volume":"10","author":"B Podlesny","year":"2023","unstructured":"Podlesny B, Hinkle KR, Hayashi K, Niidome Y, Shiraki T, Janas D. Highly-selective harvesting of (6,4) SWCNTs using the aqueous two-phase extraction method and nonionic surfactants. Adv Sci. 2023;10:2207218. https:\/\/doi.org\/10.1002\/ADVS.202207218.","journal-title":"Adv Sci"},{"key":"1541_CR42","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fbioe.2020.00210","volume":"8","author":"Q Yu","year":"2020","unstructured":"Yu Q, Zhao L, Guo C, Yan B, Su G. Regulating protein corona formation and dynamic protein exchange by controlling nanoparticle hydrophobicity. Front Bioeng Biotechnol. 2020;8:210. https:\/\/doi.org\/10.3389\/fbioe.2020.00210.","journal-title":"Front Bioeng Biotechnol."},{"key":"1541_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/1357-2725(95)00030-S","volume":"27","author":"K Woodburn","year":"1995","unstructured":"Woodburn K, Sykes E, Kessel D. Interactions of Solutol HS 15 and Cremophor EL with plasma lipoproteins. Int J Biochem Cell Biol. 1995;27:693\u20139. https:\/\/doi.org\/10.1016\/1357-2725(95)00030-S.","journal-title":"Int J Biochem Cell Biol"},{"key":"1541_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1477-3155-12-5","volume":"12","author":"L Shang","year":"2014","unstructured":"Shang L, Nienhaus K, Nienhaus GU. Engineered nanoparticles interacting with cells: size matters. J Nanobiotechnol. 2014;12:5. https:\/\/doi.org\/10.1186\/1477-3155-12-5.","journal-title":"J Nanobiotechnol"},{"key":"1541_CR45","doi-asserted-by":"publisher","first-page":"5524","DOI":"10.1021\/acsanm.8b01019","volume":"1","author":"M Suvarna","year":"2018","unstructured":"Suvarna M, Dyawanapelly S, Kansara B, Dandekar P, Jain R. Understanding the stability of nanoparticle-protein interactions: Effect of particle size on adsorption, conformation and thermodynamic properties of serum albumin proteins, ACS Appl. Nano Mater. 2018;1:5524\u201335. https:\/\/doi.org\/10.1021\/acsanm.8b01019.","journal-title":"Nano Mater"},{"key":"1541_CR46","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1002\/PAT.6179","volume":"34","author":"N Taala","year":"2023","unstructured":"Taala N, Bagheri-Khoulenjani S. Effect of initial particle size and surface charge on the formation of the plasma protein corona on chitosan-based nanoparticles. Polym Adv Technol. 2023;34:3792\u2013802. https:\/\/doi.org\/10.1002\/PAT.6179.","journal-title":"Polym Adv Technol"},{"key":"1541_CR47","doi-asserted-by":"publisher","first-page":"12881","DOI":"10.1073\/PNAS.1306529110","volume":"110","author":"CA Alabi","year":"2013","unstructured":"Alabi CA, Love KT, Sahay G, Yin H, Luly KM, Langer R, Anderson DG. Multiparametric approach for the evaluation of lipid nanoparticles for siRNA delivery. Proc Natl Acad Sci USA. 2013;110:12881\u20136. https:\/\/doi.org\/10.1073\/PNAS.1306529110.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1541_CR48","doi-asserted-by":"publisher","first-page":"121633","DOI":"10.1016\/J.IJPHARM.2022.121633","volume":"618","author":"JD Friedl","year":"2022","unstructured":"Friedl JD, J\u00f6rgensen AM, Nguyen Le NM, Steinbring C, Bernkop-Schn\u00fcrch A. Replacing PEG-surfactants in self-emulsifying drug delivery systems: surfactants with polyhydroxy head groups for advanced cytosolic drug delivery. Int J Pharm. 2022;618:121633. https:\/\/doi.org\/10.1016\/J.IJPHARM.2022.121633.","journal-title":"Int J Pharm"},{"key":"1541_CR49","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1194\/JLR.M600299-JLR200","volume":"47","author":"NM Borradaile","year":"2006","unstructured":"Borradaile NM, Han X, Harp JD, Gale SE, Ory DS, Schaffer JE. Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J Lipid Res. 2006;47:2726\u201337. https:\/\/doi.org\/10.1194\/JLR.M600299-JLR200.","journal-title":"J Lipid Res"},{"key":"1541_CR50","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1021\/ACSCHEMBIO.9B00616","volume":"14","author":"LR Parisi","year":"2019","unstructured":"Parisi LR, Sowlati-Hashjin S, Berhane IA, Galster SL, Carter KA, Lovell JF, Chemler SR, Karttunen M. Atilla-Gokcumen, membrane disruption by very long chain fatty acids during Necroptosis. ACS Chem Biol. 2019;14:2286\u201394. https:\/\/doi.org\/10.1021\/ACSCHEMBIO.9B00616.","journal-title":"ACS Chem Biol"},{"key":"1541_CR51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/J.BBAGEN.2005.06.015","volume":"1726","author":"S Dufour","year":"2005","unstructured":"Dufour S, Deleu M, Nott K, Wathelet B, Thonart P, Paquot M. Hemolytic activity of new linear surfactin analogs in relation to their physico-chemical properties. Biochim Biophys Acta - Gen Subj. 2005;1726:87\u201395. https:\/\/doi.org\/10.1016\/J.BBAGEN.2005.06.015.","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"1541_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/PHARMACEUTICS12121141","volume":"12","author":"L S\u00e9guy","year":"2020","unstructured":"S\u00e9guy L, Groo AC, Goux D, Hennequin D, Malzert-Fr\u00e9on A. Design of non-haemolytic nanoemulsions for Intravenous Administration of Hydrophobic APIs. Pharmaceutics. 2020;12:1\u201320. https:\/\/doi.org\/10.3390\/PHARMACEUTICS12121141.","journal-title":"Pharmaceutics"},{"key":"1541_CR53","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1002\/smll.201200398","volume":"8","author":"R Luo","year":"2012","unstructured":"Luo R, Neu B, Venkatraman SS. Surface functionalization of nanoparticles to control cell interactions and drug release. Small. 2012;8:2585\u201394. https:\/\/doi.org\/10.1002\/smll.201200398.","journal-title":"Small"},{"key":"1541_CR54","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.2147\/IJN.S36111","volume":"7","author":"E Fr\u00f6hlich","year":"2012","unstructured":"Fr\u00f6hlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed. 2012;7:5577\u201391. https:\/\/doi.org\/10.2147\/IJN.S36111.","journal-title":"Int J Nanomed"},{"key":"1541_CR55","first-page":"881","volume":"6","author":"L Mr\u00f3wczy\u0144ska","year":"2001","unstructured":"Mr\u00f3wczy\u0144ska L, Bielawski J. The mechanism of bile salt-induced hemolysis. Cell Mol Biol Lett. 2001;6:881\u201395.","journal-title":"Cell Mol Biol Lett"},{"key":"1541_CR56","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/JPS.20627","volume":"95","author":"K Amin","year":"2006","unstructured":"Amin K, Dannenfelser RM. In vitro hemolysis: Guidance for the pharmaceutical scientist. J Pharm Sci. 2006;95:1173\u20136. https:\/\/doi.org\/10.1002\/JPS.20627.","journal-title":"J Pharm Sci"},{"key":"1541_CR57","doi-asserted-by":"publisher","unstructured":"S\u00e6b\u00f8 IP, Bj\u00f8r\u00e5s M, Franzyk H, Helgesen E, Booth JA. Optimization of the Hemolysis Assay for the Assessment of cytotoxicity. Int J Mol Sci. 2023;24(3). https:\/\/doi.org\/10.3390\/ijms24032914.","DOI":"10.3390\/ijms24032914"},{"key":"1541_CR58","doi-asserted-by":"publisher","unstructured":"Greco I, Molchanova N, Holmedal E, Jenssen H, Hummel BD, Watts JL, H\u00e5kansson J, Hansen PR, Svenson J. Correlation between hemolytic activity, cytotoxicity and systemic in vivo toxicity of synthetic antimicrobial peptides. Sci Rep. 2020;10(1):13206. https:\/\/doi.org\/10.1038\/S41598-020-69995-9.","DOI":"10.1038\/S41598-020-69995-9"},{"key":"1541_CR59","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/J.AJPS.2020.12.002","volume":"16","author":"S Guo","year":"2021","unstructured":"Guo S, Shi Y, Liang Y, Liu L, Sun K, Li Y. Relationship and improvement strategies between drug nanocarrier characteristics and hemocompatibility: what can we learn from the literature. Asian J Pharm Sci. 2021;16:551. https:\/\/doi.org\/10.1016\/J.AJPS.2020.12.002.","journal-title":"Asian J Pharm Sci"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01541-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01541-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01541-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T14:11:33Z","timestamp":1727791893000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01541-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,27]]},"references-count":59,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1541"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01541-w","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,27]]},"assertion":[{"value":"7 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial\u00a0interests or personal relationships that could have appeared to influence the work\u00a0reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}